twinks albert and birdsim piss and fuck.desi porn
nxxx.desi
xxx sex

Allscripts Healthcare Solutions (NASDAQ:MDRX) Issues Earnings Results, Beats Expectations By $0.03 EPS


Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) released its quarterly earnings results on Thursday. The software maker reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.03, Briefing.com reports. The business had revenue of $150.90 million during the quarter, compared to analyst estimates of $148.58 million. Allscripts Healthcare Solutions had a net margin of 5.90% and a return on equity of 10.24%. The business’s revenue was up 6.9% on a year-over-year basis. During the same period last year, the business earned $0.17 EPS.

Allscripts Healthcare Solutions Stock Performance

Shares of Allscripts Healthcare Solutions stock traded up $2.08 during trading hours on Friday, reaching $17.53. The company’s stock had a trading volume of 3,122,237 shares, compared to its average volume of 1,055,445. The company’s 50 day simple moving average is $15.57 and its 200 day simple moving average is $18.80. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.38 and a current ratio of 2.38. Allscripts Healthcare Solutions has a one year low of $13.05 and a one year high of $23.25. The stock has a market cap of $2.03 billion, a P/E ratio of 40.77, a price-to-earnings-growth ratio of 1.41 and a beta of 1.02.

Insider Transactions at Allscripts Healthcare Solutions

In other news, Director Paul Black sold 60,000 shares of the firm’s stock in a transaction dated Friday, June 10th. The shares were sold at an average price of $16.58, for a total value of $994,800.00. Following the transaction, the director now directly owns 1,254,631 shares in the company, valued at approximately $20,801,781.98. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Paul Black sold 60,000 shares of the firm’s stock in a transaction dated Friday, June 10th. The shares were sold at an average price of $16.58, for a total value of $994,800.00. Following the transaction, the director now directly owns 1,254,631 shares in the company, valued at approximately $20,801,781.98. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Thomas Langan sold 51,537 shares of the firm’s stock in a transaction dated Tuesday, May 10th. The stock was sold at an average price of $18.12, for a total transaction of $933,850.44. Following the completion of the transaction, the insider now owns 139,912 shares in the company, valued at $2,535,205.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 318,015 shares of company stock worth $5,550,054. 2.29% of the stock is currently owned by insiders.

Institutional Trading of Allscripts Healthcare Solutions

A number of large investors have recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Allscripts Healthcare Solutions by 4.4% in the 1st quarter. Vanguard Group Inc. now owns 13,852,474 shares of the software maker’s stock worth $311,957,000 after acquiring an additional 584,339 shares during the period. State Street Corp increased its holdings in shares of Allscripts Healthcare Solutions by 3.2% in the 1st quarter. State Street Corp now owns 4,448,241 shares of the software maker’s stock worth $100,174,000 after acquiring an additional 136,905 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Allscripts Healthcare Solutions by 10.8% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,422,121 shares of the software maker’s stock worth $32,027,000 after acquiring an additional 139,142 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of Allscripts Healthcare Solutions by 3.1% in the 1st quarter. Bank of New York Mellon Corp now owns 1,323,414 shares of the software maker’s stock worth $29,803,000 after acquiring an additional 39,210 shares during the period. Finally, Royal Bank of Canada increased its holdings in shares of Allscripts Healthcare Solutions by 9.5% in the 1st quarter. Royal Bank of Canada now owns 1,316,473 shares of the software maker’s stock worth $29,647,000 after acquiring an additional 113,940 shares during the period.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. TheStreet lowered shares of Allscripts Healthcare Solutions from a “b” rating to a “c” rating in a report on Friday, May 6th. Piper Sandler lowered their price target on shares of Allscripts Healthcare Solutions from $19.00 to $17.00 in a report on Thursday, June 9th. StockNews.com downgraded shares of Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Friday, May 13th. Finally, The Goldman Sachs Group assumed coverage on shares of Allscripts Healthcare Solutions in a research note on Tuesday, July 12th. They set a “neutral” rating and a $21.00 price objective on the stock. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, Allscripts Healthcare Solutions has a consensus rating of “Moderate Buy” and a consensus target price of $21.33.

Allscripts Healthcare Solutions Company Profile

(Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Earnings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Allscripts Healthcare Solutions right now?

Before you consider Allscripts Healthcare Solutions, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Allscripts Healthcare Solutions wasn’t on the list.

While Allscripts Healthcare Solutions currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here



Source link

girlfriends having fun with their favorite toy.amateur girls double dong full insertion.
pornsnake.net
sex tube my golden pussy is not beautiful and.